135 related articles for article (PubMed ID: 21204253)
1. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder.
Sussulini A; Dihazi H; Banzato CE; Arruda MA; Stühmer W; Ehrenreich H; Jahn O; Kratzin HD
Proteomics; 2011 Jan; 11(2):261-9. PubMed ID: 21204253
[TBL] [Abstract][Full Text] [Related]
2. Metallomics studies of human blood serum from treated bipolar disorder patients.
Sussulini A; Kratzin H; Jahn O; Banzato CE; Arruda MA; Becker JS
Anal Chem; 2010 Jul; 82(13):5859-64. PubMed ID: 20536186
[TBL] [Abstract][Full Text] [Related]
3. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
4. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
5. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
6. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.
Hajek T; Bauer M; Simhandl C; Rybakowski J; O'Donovan C; Pfennig A; König B; Suwalska A; Yucel K; Uher R; Young LT; MacQueen G; Alda M
Psychol Med; 2014 Feb; 44(3):507-17. PubMed ID: 23721695
[TBL] [Abstract][Full Text] [Related]
8. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment.
Knijff EM; Breunis MN; Kupka RW; de Wit HJ; Ruwhof C; Akkerhuis GW; Nolen WA; Drexhage HA
Bipolar Disord; 2007 Nov; 9(7):743-53. PubMed ID: 17988365
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
10. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
11. No association between the PREP gene and lithium responsive bipolar disorder.
Mamdani F; Sequeira A; Alda M; Grof P; Rouleau G; Turecki G
BMC Psychiatry; 2007 Feb; 7():9. PubMed ID: 17324276
[TBL] [Abstract][Full Text] [Related]
12. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
[TBL] [Abstract][Full Text] [Related]
13. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
14. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
15. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Kim J; Lazarus A
J Med Econ; 2009; 12(4):259-68. PubMed ID: 19769548
[TBL] [Abstract][Full Text] [Related]
17. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
[TBL] [Abstract][Full Text] [Related]
19. Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Ketter TA; Calabrese JR; Thase ME; Bowden CL; Friedman ES; Ostacher MJ; Novak L; Iosifescu DV;
Clin Trials; 2009 Dec; 6(6):637-48. PubMed ID: 19933719
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
